1. Home
  2. SLS vs ACNT Comparison

SLS vs ACNT Comparison

Compare SLS & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • ACNT
  • Stock Information
  • Founded
  • SLS 2012
  • ACNT 1945
  • Country
  • SLS United States
  • ACNT United States
  • Employees
  • SLS N/A
  • ACNT N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • ACNT Steel/Iron Ore
  • Sector
  • SLS Health Care
  • ACNT Industrials
  • Exchange
  • SLS Nasdaq
  • ACNT Nasdaq
  • Market Cap
  • SLS 100.6M
  • ACNT 113.9M
  • IPO Year
  • SLS N/A
  • ACNT N/A
  • Fundamental
  • Price
  • SLS $1.27
  • ACNT $10.97
  • Analyst Decision
  • SLS
  • ACNT
  • Analyst Count
  • SLS 0
  • ACNT 0
  • Target Price
  • SLS N/A
  • ACNT N/A
  • AVG Volume (30 Days)
  • SLS 4.1M
  • ACNT 18.4K
  • Earning Date
  • SLS 03-27-2025
  • ACNT 03-04-2025
  • Dividend Yield
  • SLS N/A
  • ACNT N/A
  • EPS Growth
  • SLS N/A
  • ACNT N/A
  • EPS
  • SLS N/A
  • ACNT N/A
  • Revenue
  • SLS N/A
  • ACNT $178,417,000.00
  • Revenue This Year
  • SLS N/A
  • ACNT $5.81
  • Revenue Next Year
  • SLS N/A
  • ACNT $6.79
  • P/E Ratio
  • SLS N/A
  • ACNT N/A
  • Revenue Growth
  • SLS N/A
  • ACNT 6.56
  • 52 Week Low
  • SLS $0.77
  • ACNT $8.16
  • 52 Week High
  • SLS $1.84
  • ACNT $12.38
  • Technical
  • Relative Strength Index (RSI)
  • SLS 50.97
  • ACNT 44.34
  • Support Level
  • SLS $1.20
  • ACNT $10.96
  • Resistance Level
  • SLS $1.37
  • ACNT $11.68
  • Average True Range (ATR)
  • SLS 0.14
  • ACNT 0.28
  • MACD
  • SLS -0.02
  • ACNT -0.00
  • Stochastic Oscillator
  • SLS 10.94
  • ACNT 1.39

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About ACNT Ascent Industries Co.

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Ascent Tubular Products and the Specialty Chemicals Segment. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive and commercial transportation, brewery, chemical, petrochemical and other industries. The Specialty Chemicals segment produces specialty products for the pulp and paper, coatings, adhesives, sealants and elastomers (CASE), textile, automotive, household and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

Share on Social Networks: